CryoMass Technologies Inc. has signed a license agreement with RubberRock Inc. (RubberRock) co-owned by famed extractor Brad Robertson, co-founder of Guild Extracts. After demonstrating the trichome separation capabilities of the CryoSift Separator??, CryoMass most important objective was finding the most efficient and scalable way to utilize CryoSift?? for large scale cannabinoid production.

This meant finding partners with deep extraction expertise open to new methods beyond existing extraction processes. Current extraction techniques utilize full biomass, not refined and concentrated input material like CryoSift??. CryoMass found an ideal partner in pioneer extractor Brad Robertson.

In 2015, Robertson and Guild Extracts were the first to isolate and commercialize high-purity THCa crystalline, the natural form of THC found in raw cannabis plants. Robertson holds two patents for efficiently extracting and isolating cannabinoids and terpenes using proprietary methods. His ability to produce pure cannabinoids faster, with less solvent, and in higher yields than other processors put him in a class of his own.

THCa crystalline: Robertson's innovative approach mirrors the way CryoMass developed its trichome separation process due to the creative thinking of Matt Armstrong, CryoMass Senior Director of Innovation, and willingness to explore new methods. CryoMass identified Brad and his team as the right partner since RubberRock already produces cannabinoid ingredients faster, more efficiently, and cheaper than most processors. Combining CryoMass's patented refinement with Brad's proprietary extraction will enable unprecedented scale and cost efficiency in cannabinoid production.

Under the agreement terms, CryoMass receives a territory licensing fee and ongoing royalties. The royalties include 25% of gross revenue from any cannabinoid extracts, ingredients or formulations utilizing CryoSift?. Minimum quarterly royalties, starting at $100,000 and reaching $750,000 by fourth quarter 2024, guarantee CryoMass at least $3 million in annual royalties.

This recurring revenue stream positions CryoMass to potentially reach profitability from a single system. Commercialization Update: With strong demand and solid pipeline, CryoMass continues selectively vetting partners to deploy its technology across key markets, while upholding standards for controlled growth. The company has fielded over 200 inquiries from 20+ countries and 10+ states, engaging with 70+ prospects and is actively involved in conversations with 25+ of them.

Near-term plans target two additional unit deployments in strategic regions.